Ticker
BCTXCompany Name
BRIACELL THERAPEUTICS CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Core Assets | Goodwill and Intangibles |
---|---|---|---|---|
3/31/2025 | $ 17M | $ 12.46M | $ 4.35M | $ 188.34K |
12/31/2024 | $ 9.36M | $ 5.01M | $ 4.16M | $ 192.16K |
9/30/2024 | $ 10.41M | $ 5.79M | $ 4.43M | $ 195.98K |
6/30/2024 | $ 5.87M | $ 862.09K | $ 4.81M | $ 199.8K |
3/31/2024 | $ 6.2M | $ 935.69K | $ 5.06M | $ 203.61K |
12/31/2023 | $ 12.23M | $ 6.24M | $ 5.78M | $ 207.43K |
9/30/2023 | $ 18.62M | $ 13.65M | $ 4.76M | $ 211.25K |
6/30/2023 | $ 27.16M | $ 21.25M | $ 5.7M | $ 215.07K |
3/31/2023 | $ 29.72M | $ 28.17M | $ 1.33M | $ 218.89K |
12/31/2022 | $ 34.16M | $ 33.5M | $ 438.33K | $ 222.7K |
Assets - Intangibles - CashnEq
(=) Core Assets
Core Assets for BRIACELL THERAPEUTICS CORP is calculated as follows: Assets [ $ 494.1K ] - Intangibles [ $ 246.76K ] - CashnEq [ $ 20.1K ]
(=) Core Assets [ $ 227.23K ]
Minimum
Dec 31, 2020
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.42K |
---|---|
min | $ 0 |
max | $ 4.42B |
average | $ 805.95M |
median | $ 292.02M |
std | $ 1.06B |